Get the App
A

Allogene (ALLO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Allogene (ALLO)

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more

  • USD5.00
  • USD5.16
  • USD4.88
  • USD17.49
  • -18.90%
  • 0M
  • 1.39M
  • 2.13M
  • 725M
  • 4.91
  • -49.40%

Stock News

Top 50 Perfume Brands in the World

1 hour ago

Top 50 Perfume Brands in the World

Yahoo

: Fiery French protests and widespread Israeli strike reflect discord with democracy. The U.S. is not immune.

1 hour ago

: Fiery French protests and widespread Israeli strike reflect discord with democracy. The U.S. is not immune.

MarketWatch

S&P Global Commodity Insights Launches eWindow® for Asian Biofuels and Feedstock

2 hours ago

S&P Global Commodity Insights Launches eWindow® for Asian Biofuels and Feedstock

Yahoo

Alibaba to decide on control over new business units after IPOs

3 hours ago

Alibaba to decide on control over new business units after IPOs

Reuters

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium